How Your Lymphatic System Keeps You Healthy: Must-Know Facts!

How Your Lymphatic System Keeps You Healthy: Must-Know Facts!

The lymphatic system forms an extensive network throughout our body and is crucial for maintaining fluid balance and immune function. Comprising lymph, lymph vessels, and lymph nodes, the lymphatic system works diligently to keep our body healthy. This article delves into the parts and functions of the lymphatic system, explaining its importance in detail.  Lymph: […]

Akthelia Pharmaceuticals gets EU Horizon Grant for IN-ARMOR project

Akthelia Pharmaceuticals gets EU Horizon Grant for IN-ARMOR project

Akthelia Pharmaceuticals, a preclinical drug development startup, and the University of Iceland have jointly secured a €6 million EU Horizon Grant for the IN-ARMOR project. The joint IN-ARMOR project is anticipated to develop new innate immune system inducers to deal with antimicrobial resistance (AMR), a global health threat, and minimize infections, including two of the […]

Glenmark Pharmaceuticals set to begin clinical trial of GRC 54276 in US

Glenmark Pharmaceuticals set to begin clinical trial of GRC 54276 in US

Glenmark Pharmaceuticals, through its subsidiary Glenmark Specialty, is set to begin a first-in-human, phase 1/2 clinical study of GRC 54276 in the US for the treatment of advanced solid tumors and lymphomas. This was after Glenmark Specialty’s investigational new drug (IND) application for GRC 54276 was accepted by the US Food and Drug Administration (FDA). […]

FDA approves Janssen’s TECVAYLI for multiple myeloma treatment

FDA approves Janssen’s TECVAYLI for multiple myeloma treatment

The Janssen Pharmaceutical Companies, a subsidiary of Johnson & Johnson, announced the US Food and Drug Administration’s approval of its first bispecific T-cell engager antibody, TECVAYLI (teclistamab-cqyv). The medication is intended for the treatment of relapsed or refractory multiple myeloma patients. TECVAYLI is indicated for patients previously treated with a proteasome inhibitor, immunomodulatory drug, and […]

Blender Bites launches Daily Defen-C superfood smoothie

Blender Bites launches Daily Defen-C superfood smoothie

Blender Bites, a Canadian manufacturer of organic and plant-based frozen functional foods, has launched a new superfood smoothie innovation called Daily Defen-C. According to Blender Bites, Daily Defen-C has a mix of organic fruits and functional ingredients. It is claimed to be packed with two billion plant-based probiotics per puck, ginger, camu camu, turmeric, and […]

BriaCell Therapeutics gets license for anti-cancer agent sCD80 from UMBC

BriaCell Therapeutics gets license for anti-cancer agent sCD80 from UMBC

BriaCell Therapeutics has signed an exclusive licensing deal with the University of Maryland, Baltimore County (UMBC) to develop and commercialize Soluble CD80 (sCD80) as a biologic agent for cancer treatment. sCD80 was developed originally by Suzanne Ostrand-Rosenberg from the Emeritus Faculty at UMBC. According to BriaCell Therapeutics, sCD80 was well-tolerated in animal models, and by […]

Pfizer to acquire immuno-oncology company Trillium Therapeutics for $2.2bn

Pfizer to acquire immuno-oncology company Trillium Therapeutics for $2.2bn

US pharma giant Pfizer has agreed to acquire Trillium Therapeutics, a publicly listed Canadian clinical stage immuno-oncology company, for $18.5 per share or $2.26 billion in an all-cash deal. The portfolio of Trillium Therapeutics has biologics that have been designed to boost the ability of patients’ innate immune systems for detecting and killing cancer cells. […]

Zydus Cadila gets EUA for ZyCoV-D vaccine for Covid-19 in India

Zydus Cadila gets EUA for ZyCoV-D vaccine for Covid-19 in India

Zydus Cadila (Cadila Healthcare) said that it has secured the emergency use authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D vaccine for Covid-19 for adults and also adolescents in the age group of 12-18 years. According to Zydus Cadila, ZyCoV-D is the first Plasmid DNA vaccine for Covid-19 in the world. […]